CSF-1R inhibition using either BLZ945 or PLX3397 leads to tumor regression and enhanced survival in PDGF-driven proneural GBM mouse models by modifying macrophage polarization rather than depleting these cells [43,44]. The gene discussed is CSF1R; the disease is neoplasm.